Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Post-menopausal hormone replacement therapy and stroke risk
Autore:
Kittner, SJ; Bousser, MG;
Indirizzi:
Hop Lariboisiere, Serv Neurol, F-75475 Paris 10, France Hop Lariboisiere Paris France 10 , Serv Neurol, F-75475 Paris 10, France Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA Univ Maryland Baltimore MD USA 21201 Dept Neurol, Baltimore, MD 21201 USA Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA Univ Maryland Baltimore MD USA 21201 Prevent Med, Baltimore, MD 21201 USA Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21218 USA Vet Adm Med Ctr Baltimore MD USA 21218 uc & Clin, Baltimore, MD 21218 USA
Titolo Testata:
CEPHALALGIA
fascicolo: 3, volume: 20, anno: 2000,
pagine: 208 - 213
SICI:
0333-1024(200004)20:3<208:PHRTAS>2.0.ZU;2-A
Fonte:
ISI
Lingua:
ENG
Soggetto:
CORONARY HEART-DISEASE; POSTMENOPAUSAL WOMEN; ESTROGEN REPLACEMENT; VENOUS THROMBOEMBOLISM; CARDIOVASCULAR-DISEASE; ISCHEMIC STROKE; USERS; PROGESTIN; TRIAL; LIFE;
Keywords:
hormone replacement therapy; stroke; oestrogen; progestins;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
32
Recensione:
Indirizzi per estratti:
Indirizzo: Bousser, MG Hop Lariboisiere, Serv Neurol, 2 Rue Ambroise Pare, F-75475 Paris 10, France Hop Lariboisiere 2 Rue Ambroise Pare Paris France 10 , France
Citazione:
S.J. Kittner e M.G. Bousser, "Post-menopausal hormone replacement therapy and stroke risk", CEPHALALGIA, 20(3), 2000, pp. 208-213

Abstract

This paper will review available data bearing on the relationship of post-menopausal hormone replacement therapy to the risk of first or recurrent ischaemic stroke. Although experimental data from both human and animal studies will be briefly mentioned, the bulk of evidence is from observational epidemiological studies. As such, the limitations of observational studies, particularly as applied to the health effects of post-menopausal hormone replacement therapy, will be emphasized. We conclude that there is no compelling consistent evidence that post-menopausal hormone replacement therapy either decreases or increases stroke risk. There are, however, reasons to be concerned that this therapy may contribute to stroke risk.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 16:09:49